Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets (2019 - 2023)

Historic Assets for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $466.9 million.

  • ADC Therapeutics' Assets fell 1219.71% to $466.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $466.9 million, marking a year-over-year decrease of 1219.71%. This contributed to the annual value of $490.9 million for FY2022, which is 11.63% down from last year.
  • Latest data reveals that ADC Therapeutics reported Assets of $466.9 million as of Q3 2023, which was down 1219.71% from $507.3 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Assets high stood at $638.0 million for Q3 2021, and its period low was $137682.0 during Q4 2019.
  • Its 5-year average for Assets is $401.7 million, with a median of $479.3 million in 2022.
  • Its Assets has fluctuated over the past 5 years, first soared by 12411985.76% in 2021, then crashed by 1962.82% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Assets stood at $137682.0 in 2019, then surged by 278.79% to $521526.0 in 2020, then soared by 94129.37% to $491.4 million in 2021, then dropped by 0.12% to $490.9 million in 2022, then dropped by 4.88% to $466.9 million in 2023.
  • Its last three reported values are $466.9 million in Q3 2023, $507.3 million for Q2 2023, and $467.7 million during Q1 2023.